메뉴 건너뛰기




Volumn 91, Issue 3, 2011, Pages 357-358

Serious adverse events reporting on systemic terbinafne: A danish register-based study

Author keywords

[No Author keywords available]

Indexed keywords

TERBINAFINE; ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE;

EID: 79955721269     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1041     Document Type: Letter
Times cited : (14)

References (7)
  • 2
    • 34548187423 scopus 로고    scopus 로고
    • The safety of oral antifungal treatments for superfcial dermato-phytosis and onychomycosis: A meta-analysis
    • Chang CH, Young-Xu Y, Kurth T, Orav EJ, Chan KA. The safety of oral antifungal treatments for superfcial dermato-phytosis and onychomycosis: a meta-analysis. Am J Med 2007; 120: 791-798.
    • (2007) Am J Med , vol.120 , pp. 791-798
    • Chang, C.H.1    Young-Xu, Y.2    Kurth, T.3    Orav, E.J.4    Chan, K.A.5
  • 3
    • 33845340225 scopus 로고    scopus 로고
    • Safety and tolerability of oral anti-fungal agents in the treatment of fungal nail disease: A proven reality
    • Elewski B, Tavakkol A. Safety and tolerability of oral anti-fungal agents in the treatment of fungal nail disease: a proven reality. Ther Clin Risk Manag 2005; 1: 299-306.
    • (2005) Ther Clin Risk Manag , vol.1 , pp. 299-306
    • Elewski, B.1    Tavakkol, A.2
  • 4
    • 15744368600 scopus 로고    scopus 로고
    • The life-threatening complications of dermatologic therapies
    • Orion E, Matz H, Wolf R. The life-threatening complications of dermatologic therapies. Clin Dermatol 2005; 23: 182-192.
    • (2005) Clin Dermatol , vol.23 , pp. 182-192
    • Orion, E.1    Matz, H.2    Wolf, R.3
  • 5
    • 0030824856 scopus 로고    scopus 로고
    • Safety of oral terbinafne: Results of a postmarketing surveillance study in 25,884 patients
    • Hall M, Monka C, Krupp P, O'Sullivan D. Safety of oral terbinafne: results of a postmarketing surveillance study in 25,884 patients. Arch Dermatol 1997; 33: 1213-1219.
    • (1997) Arch Dermatol , vol.33 , pp. 1213-1219
    • Hall, M.1    Monka, C.2    Krupp, P.3    O'Sullivan, D.4
  • 6
    • 0029828328 scopus 로고    scopus 로고
    • Postmarketing surveillance of oral terbinafne in the UK: Report of a large cohort study
    • O'Sullivan DP, Needham CA, Bangs A, Atkin K, Kendall FD. Postmarketing surveillance of oral terbinafne in the UK: report of a large cohort study. Br J Clin Pharmacol 1996; 42: 559-565.
    • (1996) Br J Clin Pharmacol , vol.42 , pp. 559-565
    • O'Sullivan, D.P.1    Needham, C.A.2    Bangs, A.3    Atkin, K.4    Kendall, F.D.5
  • 7
    • 34250652007 scopus 로고    scopus 로고
    • A multicentre, randomized, controlled study of the effcacy, safety and cost-effectiveness of a combination therapy with amorolfne nail lacquer and oral terbinafne compared with oral terbinafne alone for the treatment of onychomycosis with matrix involvement
    • Baran R, Sigurgeirsson B, de Berker D, Kaufmann R, Lecha M, Faergemann J, et al. A multicentre, randomized, controlled study of the effcacy, safety and cost-effectiveness of a combination therapy with amorolfne nail lacquer and oral terbinafne compared with oral terbinafne alone for the treatment of onychomycosis with matrix involvement. Br J Dermatol 2007; 157: 149-157.
    • (2007) Br J Dermatol , vol.157 , pp. 149-157
    • Baran, R.1    Sigurgeirsson, B.2    de Berker, D.3    Kaufmann, R.4    Lecha, M.5    Faergemann, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.